SBA-type mesoporous materials with cylindrical and spherical structures for the controlled loading and release of ibuprofen
Source abstract
Abstract
In this work, three kinds of mesoporous silica materials: SBA-15, SBA-16, and DIM (mixture of two type of mesopores) with different morphologies and array of mesopores (hexagonal, cubic, and hexagonal-cubic, respectively) were prepared, characterized and employed as ibuprofen (IBU) carriers to study the influence of mesoporous structure on drug delivery property. The results obtained indicated that the amount of loaded IBU decreased in the following order: DIM > SBA-15 > SBA-16. The drug release profiles showed two stages, beginning with (a) a fast medicament liberation during the first hours, followed by (b) a slower drug release until the end of the test. Also, these results indicate that materials with different morphology presented different loading and release behaviors, thus, we could be able to control the drug release rate. The materials with two different types of pore permit better diffusion of the drug molecule and therefore lead to a higher loading and faster releasing than that of only one kind mesoporous in this case, SBA-15 y SBA-16. Based on these results, we can design mesoporous materials according to the dosage and the delivery kinetics of a specific pharmacological molecule.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Mesoporous Materials and Catalysis · Nanoparticle-Based Drug Delivery · Advanced Drug Delivery Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (41)
Show source-provided references
1. Perego C, Millini R (2013) Porous materials in catalysis: challenges for mesoporous materials. Chem Soc Rev 42(9):3956–397610.1039/C2CS35244C ↗
2. Wagner T, Haffer S, Weinberger C, Klaus D, Tiemann M (2013) Mesoporous materials as gas sensors. Chem Soc Rev 42(9):4036–405310.1039/C2CS35379B ↗
3. Kalmár J, Kéri M, Erdei Z, Bányai I, Lázár I, Lente G, Fábián I (2015) The pore network and the adsorption characteristics of mesoporous silica aerogel: adsorption kinetics on a timescale of seconds. RSC Adv 5(130):107237–10724610.1039/C5RA21353C ↗
4. Goscianska J, Olejnik A, Pietrzak R (2013) Adsorption of l-phenylalanine onto mesoporous silica. Mater Chem Phys 142(2):586–59310.1016/j.matchemphys.2013.07.057 ↗
5. Xu W, Riikonen J, Lehto VP (2013) Mesoporous systems for poorly soluble drugs. Int J Pharm 453(1):181–19710.1016/j.ijpharm.2012.09.008 ↗
6. Mäkilä E, Kivela H, Shrestha N, Correia A, Kaasalainen M, Kukk E, Salonen J (2016) Influence of surface chemistry on ibuprofen adsorption and confinement in mesoporous silicon microparticles. Langmuir 32(49):13020–1302910.1021/acs.langmuir.6b03413 ↗
7. Legnoverde MS, Simonetti S, Basaldella EI (2014) Influence of pH on cephalexin adsorption onto SBA-15 mesoporous silica: theoretical and experimental study. Appl Surf Sci 300:37–4210.1016/j.apsusc.2014.01.198 ↗
8. Legnoverde MS, Basaldella EI (2016) Influence of particle size on the adsorption and release of cephalexin encapsulated in mesoporous silica SBA-15. Mater Lett 181:331–33410.1016/j.matlet.2016.06.053 ↗
9. Vallet‐Regí M, Balas F, Arcos D (2007) Mesoporous materials for drug delivery. Angew Chem Int Ed 46(40):7548–755810.1002/anie.200604488 ↗
10. Izquierdo-Barba I, Sousa E, Doadrio JC, Doadrio AL, Pariente JP, Martínez A, Vallet-Regí M (2009) Influence of mesoporous structure type on the controlled delivery of drugs: release of ibuprofen from MCM-48, SBA-15 and functionalized SBA-15. J Sol-Gel Sci Technol 50(3):421–42910.1007/s10971-009-1932-3 ↗
11. Hashemikia S, Hemmatinejad N, Ahmadi E, Montazer M (2015) Optimization of tetracycline hydrochloride adsorption on amino modified SBA-15 using response surface methodology. J Colloid Interface Sci 443:105–11410.1016/j.jcis.2014.11.020 ↗
12. Naghiloo M, Yousefpour M, Nourbakhsh MS, Taherian Z (2015) Functionalization of SBA-16 silica particles for ibuprofen delivery. J Sol-Gel Sci Technol 74(2):537–54310.1007/s10971-015-3631-6 ↗
13. de Oliveira Freitas LB, Bravo IJG, de Almeida Macedo WA, de Sousa EMB (2016) Mesoporous silica materials functionalized with folic acid: preparation, characterization and release profile study with methotrexate. J Sol-Gel Sci Technol 77(1):186–20410.1007/s10971-015-3844-8 ↗
14. Reber MJ, Brühwiler D (2015) Bimodal mesoporous silica with bottleneck pores. Dalton Trans 44(41):17960–1796710.1039/C5DT03082J ↗
15. Chu WC, Peng DR, Bastakoti BP, Pramanik M, Malgras V, Ahamad T, Kuo SW (2016) Co–templating synthesis of bimodal mesoporous silica for potential drug carrier. ChemistrySelect 1(7):1339–134610.1002/slct.201600406 ↗
16. Jullaphan O, Witoon T, Chareonpanich M (2009) Synthesis of mixed-phase uniformly infiltrated SBA-3-like in SBA-15 bimodal mesoporous silica from rice husk ash. Mater Lett 63(15):1303–130610.1016/j.matlet.2009.03.001 ↗
17. Morales JM, Moragues A, El Haskouri J, Guillem C, Latorre J, Murcia‐Mascarós S, Amorós P (2015) Low‐cost synthesis of bimodal mesoporous silica‐based materials by pseudomorphic ransformation. ChemPlusChem 80(6):1014–102810.1002/cplu.201402383 ↗
18. Ojeda ML, Campero A, López-Cortés JG, Ortega-Alfaro MC, Velásquez C, Alvarez C (2008) Incorporation of a tungsten Fischer-type metal carbene covalently bound to functionalized SBA-15. Microporous Mesoporous Mater 111(1):178–18710.1016/j.micromeso.2007.07.026 ↗
19. Kleitz F, Kim T, Ryoo R (2005) Design of mesoporous silica at low acid concentrations in triblock copolymer-butanol-water systems. Bull-Korean Chem Soc 26(11):1653–166810.5012/bkcs.2005.26.11.1653 ↗
20. Kleitz F, Kim TW, Ryoo R (2006) Phase domain of the cubic Im 3̄ m mesoporous silica in the EO106PO70EO106− Butanol− H2O system. Langmuir 22(1):440–44510.1021/la052047+ ↗
21. Velásquez C, Ojeda ML, Campero A, Esparza JM, Rojas F (2008) Development and vapor sorption assessment of dimorphic SiO2 porous substrates. J Mol Catal A: Chem 281(1):126–13610.1016/j.molcata.2007.07.040 ↗
22. Zheng J, Tian X, Sun Y, Lu D, Yang W (2013) pH-sensitive poly (glutamic acid) grafted mesoporous silica nanoparticles for drug delivery. Int J Pharm 450(1):296–30310.1016/j.ijpharm.2013.04.014 ↗
23. Munoz B, Ramila A, Perez-Pariente J, Diaz I, Vallet-Regi M (2003) MCM-41 organic modification as drug delivery rate regulator. Chem Mater 15(2):500–50310.1021/cm021217q ↗
24. Jaroniec CP, Gilpin RK, Jaroniec M (1997) Adsorption and thermogravimetric studies of silica-based amide bonded phases. J Phys Chem B 101(35):6861–686610.1021/jp964002a ↗
25. Dhar GM, Kumaran GM, Kumar M, Rawat KS, Sharma LD, Raju BD, Rao KR (2005) Physico-chemical characterization and catalysis on SBA-15 supported molybdenum hydrotreating catalysts. Catal Today 99(3):309–31410.1016/j.cattod.2004.10.005 ↗
26. Kumaran GM, Garg S, Soni K, Kumar M, Sharma LD, Dhar GM, Rao KR (2006) Effect of Al-SBA-15 support on catalytic functionalities of hydrotreating catalysts: I. Effect of variation of Si/Al ratio on catalytic functionalities. Appl Catal A: Gen 305(2):123–12910.1016/j.apcata.2006.02.057 ↗
27. Xu Y, Wang C, Zhou G, Wu Y, Chen J (2012) Improving the controlled release of water-insoluble emodin from amino-functionalized mesoporous silica. Appl Surf Sci 258(17):6366–637210.1016/j.apsusc.2012.03.041 ↗
28. Kim H, Jung JC, Kim P, Yeom SH, Lee KY, Song IK (2006) Preparation of H3PMo12O40 catalyst immobilized on surface modified mesostructured cellular foam (SM-MCF) silica and its application to the ethanol conversion reaction. J Mol Catal A: Chem 259(1):150–15510.1016/j.molcata.2006.06.032 ↗
29. Mesa M, Sierra L, Patarin J, Guth JL (2005) Morphology and porosity characteristics control of SBA-16 mesoporous silica. Effect of the triblock surfactant Pluronic F127 degradation during the synthesis. Solid State Sci 7(8):990–99710.1016/j.solidstatesciences.2005.04.006 ↗
30. Sharma KK, Asefa T (2007) Efficient bifunctional nanocatalysts by simple postgrafting of spatially isolated catalytic groups on mesoporous materials. Angew Chem 119(16):2937–294010.1002/ange.200604570 ↗
31. Charnay C, Bégu S, Tourné-Péteilh C, Nicole L, Lerner DA, Devoisselle JM (2004) Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property. Eur J Pharm Biopharm 57(3):533–54010.1016/j.ejpb.2003.12.007 ↗
32. Oliveira FJ, Melo MA, Airoldi C (2013) Inorganic–organic hybrids presenting high basic center content: SBA-15 incorporation, toxic metals sorption and energetic behavior. Mater Res Bull 48(3):1045–105610.1016/j.materresbull.2012.11.099 ↗
33. Andrade GF, Soares DCF, de Sousa Almeida RK, Sousa EMB (2012) Mesoporous silica SBA-16 functionalized with alkoxysilane groups: preparation, characterization, and release profile study. J Nanomater 2012:75
34. Zhu YF, Shi JL, Li YS, Chen HR, Shen WH, Dong XP (2005) Storage and release of ibuprofen drug molecules in hollow mesoporous silica spheres with modified pore surface. Microporous Mesoporous Mater 85(1):75–8110.1016/j.micromeso.2005.06.015 ↗
35. Sevimli F, Yılmaz A (2012) Surface functionalization of SBA-15 particles for amoxicillin delivery. Microporous Mesoporous Mater 158:281–29110.1016/j.micromeso.2012.02.037 ↗
36. Kruk M, Jaroniec M (2001) Gas adsorption characterization of ordered organic–inorganic nanocomposite materials. Chem Mater 13:3169–318310.1021/cm0101069 ↗
37. Goscianska J, Olejnik A, Nowak I, Marciniak M, Pietrzak R (2015) Ordered mesoporous silica modified with lanthanum for ibuprofen loading and release behaviour. Eur J Pharm Biopharm 94:550–55810.1016/j.ejpb.2015.07.003 ↗
38. Zhao W, Chen H, Li Y, Li L, Lang M, Shi J (2008) Uniform rattle‐type hollow magnetic mesoporous spheres as drug delivery carriers and their sustained‐release property. Adv Funct Mater 18(18):2780–278810.1002/adfm.200701317 ↗
39. Kim HJ, Ahn JE, Haam S, Shul YG, Song SY, Tatsumi T (2006) Synthesis and characterization of mesoporous Fe/SiO2 for magnetic drug targeting. J Mater Chem 16(17):1617–162110.1039/b514433g ↗
40. Higuchi T (1963) Mechanism of sustained‐action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 52(12):1145–114910.1002/jps.2600521210 ↗
41. Xu W, Riikonen J, Lehto VP (2013) Mesoporous systems for poorly soluble drugs. Int J Pharm 453(1):181–19710.1016/j.ijpharm.2012.09.008 ↗